HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Online-Only Appendix All Versions of this Article: db07-0761v1 db07-0761v2 db07-0761v3 57/4/1043    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Seok Kang, E. Articles by Chul Lee, H. Search for Related Content PubMed PubMed Citation Articles by Seok Kang, E. Articles by Chul Lee, H. Social Bookmarking                What's this?

A Polymorphism in the Zinc Transporter Gene, SLC30A8, Confers Resistance Against Posttransplantation Diabetes Mellitus in Renal Allograft Recipients

¹Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
²Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea
³Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
⁴Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
⁵The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea
⁶Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea
⁷Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, Seoul, Korea

Objective: Posttransplantation diabetes mellitus (PTDM) is a major metabolic complication in renal transplant recipients, and insulin secretory defects play an important role in the pathogenesis of PTDM. The R325W (rs13266634) nonsynonymous polymorphism in the islet-specific zinc transporter protein gene, SLC30A8, has been reported to be associated with type 2 diabetes and possibly with a defect in insulin secretion. This study investigated the association between genetic variations in the SLC30A8 and PTDM in renal allograft recipients.

Research Design and Methods: A total of 624 unrelated renal allograft recipients without previously diagnosed diabetes were enrolled. Rs13266634 was genotyped in the cohort, which consisted of 174 PTDM patients and 450 non-PTDM subjects. The genotyping of the SLC30A8 polymorphism was performed using real-time PCR.

Results: The prevalence of PTDM was 33.8% in patients carrying the R/R genotype, 26.8% in patients with the R/W genotype, and 19.8% in patients with the W/W genotype. There was a strong association between the number of W alleles and PTDM risk reduction (p for trend=0.007). Patients with at least one T allele showed a decreased risk of PTDM compared to those with the R/R genotype (R/W; risk ratio=0.78, p=0.126, W/W; risk ratio= 0.52, p=0.007). The effect of the SLC30A8 genotype remained significant after adjustments for age, gender, body weight gain, and type of immunosuppressant (R/W; hazard ratio=0.77, p=0.114, W/W; hazard ratio=0.58, p=0.026).

Conclusions: These data provide evidence that the SLC30A8 rs13266634 gene variation is associated with protection from the development of PTDM in renal allograft recipients.

Correspondence: endohclee{at}yumc.yonsei.ac.kr

Key Words: Posttransplantation diabetes mellitus (PTDM) • Genetic variation • SLC30A8 • Zinc transporter • Insulin secretion

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?